India Medicine Sales Grow 12% to ₹70,180 Crore in Sept Quarter
India’s medicine sales rose 12% to ₹70,180 crore in the September quarter, a fourth straight double-digit gain led by cardiac, diabetes and cancer drugs.
India’s medicine sales rose 12% to ₹70,180 crore in the September quarter, a fourth straight double-digit gain led by cardiac, diabetes and cancer drugs.
Mankind Pharma’s Q2 FY27 net profit rose 37.7% to ₹716 crore on 17.3% revenue growth to ₹4,338 crore, led by cardiac and anti-diabetes demand in India, 33% export growth and a 210 bps EBITDA margin expansion to 27.1%.